The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children

Blood

Volumn 110, Issue 4, 2007, Pages 1251-1261

  Clappier, Emmanuelle ^a,c   Cuccuini, Wendy ^a,b   Kalota, Anna ^d   Crinquette, Antoine ^a   Cayuela, Jean Michel ^a,b   Dik, Willem A ^e   Langerak, Anton W ^e   Montpellier, Bertrand ^f   Nadel, Bertrand ^f   Walrafen, Pierre ^g   Delattre, Olivier ^h   Aurias, Alain ^h   Leblanc, Thierry ^b   Dombret, Hervé ^b   Gewirtz, Alan M ^d   Baruchel, André ^b   Sigaux, François ^a,b   Soulier, Jean ^a,b,i  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^g Genomic Vision   (France)

^h INSTITUT CURIE   (France)

ⁱ UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADOLESCENT; ADULT; AGED; ALLELE; ANIMAL CELL; ARTICLE; CHILD; CHROMOSOME 6Q; CHROMOSOME 7Q; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 6; CHROMOSOME TRANSLOCATION 7; DNA HYBRIDIZATION; DOWN REGULATION; GENE DUPLICATION; GENE EXPRESSION; GENE LOCATION; GENE LOCUS; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION; T CELL LEUKEMIA;

EID: 34548009617     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-12-064683     Document Type: Article

References (69)

1. Weston K. Myb proteins in life, death and differentiation. Curr Opin Genet Dev. 1998;8:76-81.
2. Oh IH, Reddy EP. The myb gene family in cell growth, differentiation and apoptosis. Oncogene. 1999;18:3017-3033.
3. Mucenski ML, McLain K, Kier AB, et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 1991;65:677-689.
4. Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, Frampton J. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J. 2003;22:4478-4488.
5. Sandberg ML, Sutton SE, Pletcher MT, et al. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev Cell. 2005;8:153-166.
6. Sakamoto H, Dai G, Tsujino K, et al. Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development. Blood. 2006;108:896-903.
7. Badiani P, Corbella P, Kioussis D, Marvel J, Weston K. Dominant interfering alleles define a role for c-Myb in T-cell development. Genes Dev. 1994;8:770-782.
8. Allen RD III, Bender TP, Siu G. c-Myb is essential for early T cell development. Genes Dev. 1999;13:1073-1078.
9. Pearson R, Weston K. c-Myb regulates the proliferation of immature thymocytes following beta-selection. EMBO J. 2000;19:6112-6120.
10. Bender TP, Kremer CS, Kraus M, Buch T, Rajewsky K. Critical functions for c-Myb at three check-points during thymocyte development. Nat Immunol. 2004;5:721-729.
11. Lieu YK, Kumar A, Pajerowski AG, Rogers TJ, Reddy EP. Requirement of c-myb in T cell development and in mature T cell function. Proc Natl Acad Sci U S A. 2004;101:14853-14858.
12. Duesberg PH, Bister K, Moscovici C. Genetic structure of avian myeloblastosis virus, released from transformed myeloblasts as a defective virus particle. Proc Natl Acad Sci U S A. 1980;77:5120-5124.
13. Souza LM, Strommer JN, Hillyard RL, Komaromy MC, Baluda MA. Cellular sequences are present in the presumptive avian myeloblastosis virus genome. Proc Natl Acad Sci U S A. 1980;77:5177-5181.
14. Baluda MA, Reddy EP. Anatomy of an integrated avian myeloblastosis provirus: structure and function. Oncogene. 1994;9:2761-2774.
15. Lipsick JS, Wang DM. Transformation by v-Myb. Oncogene. 1999;18:3047-3055.
16. Badiani PA, Kioussis D, Swirsky DM, Lampert IA, Weston K. T-cell lymphomas in v-Myb transgenic mice. Oncogene. 1996;13:2205-2212.
17. Davies J, Badiani P, Weston K. Cooperation of Myb and Myc proteins in T cell lymphomagenesis. Oncogene. 1999;18:3643-3647.
18. Shen-Ong GL, Potter M, Mushinski JF, Lavu S, Reddy EP. Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas. Science. 1984;226:1077-1080.
19. Hwang HC, Martins CP, Bronkhorst Y, et al. Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis. Proc Natl Acad Sci U S A. 2002;99:11293-11298.
20. Kanter MR, Smith RE, Hayward WS. Rapid induction of B-cell lymphomas: insertional activation of c-myb by avian leukosis virus. J Virol. 1988;62:1423-1432.
21. Kim R, Trubetskoy A, Suzuki T, Jenkins NA, Copeland NG, Lenz J. Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. J Virol. 2003;77:2056-2062.
22. Lund AH, Turner G, Trubetskoy A, et al. Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice. Nat Genet. 2002;32:160-165.
23. Wolff L. Myb-induced transformation. Crit Rev Oncog. 1996;7:245-260.
24. Harper ME, Franchini G, Love J, Simon MI, Gallo RC, Wong-Staal F. Chromosomal sublocalization of human c-myb and c-fes cellular onc genes. Nature. 1983;304:169-171.
25. Slamon DJ, Boone TC, Murdock DC, et al. Studies of the human c-myb gene and its product in human acute leukemias. Science. 1986;233:347-351.
26. Barletta C, Pelicci PG, Kenyon LC, Smith SD, Dalla-Favera R. Relationship between the c-myb locus and the 6q-chromosomal aberration in leukemias and lymphomas. Science. 1987;235:1064-1067.
27. Siegert W, Beutler C, Langmach K, Keitel C, Schmidt CA. Differential expression of the oncoproteins c-myc and c-myb in human lymphoproliferative disorders. Eur J Cancer. 1990;26:733-737.
28. Ganter B, Lipsick JS. Myb and oncogenesis. Adv Cancer Res. 1999;76:21-60.
29. Introna M, Golay J. How can oncogenic transcription factors cause cancer: a critical review of the myb story. Leukemia. 1999;13:1301-1306.
30. Weston K. Reassessing the role of C-MYB in tumorigenesis. Oncogene. 1999;18:3034-3038.
31. Lutwyche JK, Keough RA, Hughes TP, Gonda TJ. Mutation screening of the c-MYB negative regulatory domain in acute and chronic myeloid leukaemia. Br J Haematol. 2001;114:632-634.
32. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004;350:1535-1548.
33. Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol. 2005;23:6306-6315.
34. Graux C, Cools J, Michaux L, Vandenberghe P, Hagemeijer A. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia. 2006;20:1496-1510.
35. Breit TM, Wolvers-Tettero IL, van Dongen JJ. Phenotypic and genotypic characteristics of human early T-cell differentiation: the T-cell acute lymphoblastic leukaemia model. Res Immunol. 1994;145:139-143; discussion: 1994;145:155-158.
36. Asnafi V, Beldjord K, Boulanger E, et al. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood. 2003;101:2693-2703.
37. Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1:75-87.
38. Soulier J, Clappier E, Cayuela JM, et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood. 2005;106:274-286.
39. Asnafi V, Radford-Weiss I, Dastugue N, et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood. 2003;102:1000-1006.
40. Ferrando AA, Armstrong SA, Neuberg DS, et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood. 2003;102:262-268.
41. Nagel S, Kaufmann M, Drexler HG, MacLeod RA. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). Cancer Res. 2003;63:5329-5334.
42. Przybylski GK, Dik WA, Grabarczyk P, et al. The effect of a novel recombination between the homeobox gene NKX2-5 and the TRD locus in T-cell acute lymphoblastic leukemia on activation of the NKX2-5 gene. Haematologica. 2006;91:317-321.
43. Cayuela JM, Madani A, Sanhes L, Stern MH, Sigaux F. Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood. 1996;87:2180-2186.
44. Gardie B, Cayuela JM, Martini S, Sigaux F. Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia. Blood. 1998;91:1016-1020.
45. Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306:269-271.
46. Grabher C, von Boehmer H, Look AT. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer. 2006;6:347-359.
47. Clappier E, Cuccuini W, Cayuela JM, et al. Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias. Leukemia. 2006;20:82-86.
48. Graux C, Cools J, Melotte C, et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet. 2004;36:1084-1089.
49. Downing JR, Mullighan CG. Tumor-specific genetic lesions and their influence on therapy in pediatric acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2006;118-122.
50. Lebofsky R, Bensimon A. Single DNA molecule analysis: applications of molecular combing. Brief Funct Genomic Proteomic. 2003;1:385-396.
51. Idbaih A, Marie Y, Pierron G, et al. Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol. 2005;58:483-487.
52. La Rosa P, Viara E, Hupe P, et al. VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles. Bioinformatics. 2006;22:2066-2073.
53. Marculescu R, Vanura K, Montpellier B, et al. Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures. DNA Repair (Amst). 2006;5:1246-1258.
54. Marculescu R, Vanura K, Le T, Simon P, Jager U, Nadel B. Distinct t(7;9)(q34;q32) breakpoints in healthy individuals and individuals with T-ALL. Nat Genet. 2003;33:342-344.
55. Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305:525-528.
56. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet. 2004;36:949-951.
57. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444-454.
58. Ross ME, Zhou X, Song G, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood. 2003;102:2951-2959.
59. Van Vlierberghe P, van Grotel M, Beverloo HB, et al. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood. 2006;108:3520-3529.
60. Chan LC, Ha SY, Ching LM, et al. Cytogenetics and immunophenotypes of childhood acute lymphoblastic leukemia in Hong Kong. Cancer Genet Cytogenet. 1994;76:118-124.
61. Heerema NA, Sather HN, Sensel MG, et al. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Clin Oncol. 1998;16:1270-1278.
62. Sinclair P, Harrison CJ, Jarosova M, Foroni L. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36). Haematologica. 2005;90:602-611.
63. Jiang X, Hanna Z, Kaouass M, Girard L, Jolicoeur P. Ahi-1, a novel gene encoding a modular protein with WD40-repeat and SH3 domains, is targeted by the Ahi-1 and Mis-2 provirus integrations. J Virol. 2002;76:9046-9059.
64. Ferland RJ, Eyaid W, Collura RV, et al. Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome. Nat Genet. 2004;36:1008-1013.
65. Jiang X, Zhao Y, Chan WY, et al. Deregulated expression in Ph- human leukemias of AHI-1, a gene activated by insertional mutagenesis in mouse models of leukemia. Blood. 2004;103:3897-3904.
66. Gewirtz AM, Anfossi G, Venturelli D, Valpreda S, Sims R, Calabretta B. G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. Science. 1989;245:180-183.
67. Calabretta B, Sims RB, Valtieri M, et al. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proc Natl Acad Sci U S A. 1991;88:2351-2355.
68. Gewirtz AM. Myb targeted therapeutics for the treatment of human malignancies. Oncogene. 1999;18:3056-3062.
69. Hess JL, Bittner CB, Zeisig DT, et al. c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. Blood. 2006;108:297-304.